Search results
74
results
29.03.2022
For Healthcare Professionals
medac at the EBMT 2022 - The latest international research outcomes at the 48th annual congress of the EBMT.
Numerous data presented at the EMBT congress from prospective and retrospective studies demonstrate the benefits of ...
22.07.2022
For Healthcare Professionals
EAU 2022: MEDSCAPE satellite symposium: “Expert Guidance in Non-Muscle-Invasive Bladder Cancer – Applying the Latest Recommendations to Clinical Practice”
With its renowned experts, the Medscape satellite symposium sponsored by medac focused on the implementation of the latest recommendations in practice.
Page
Report about a suspected adverse drug reaction
You can use this form to send us a direct message about a suspected adverse drug reaction (ADR).
Page
Experienced partner in the aseptic processing of injectables
Since our founding in 1970, we have believed in local and European production and have never considered relocating our manufacturing facilities to non-European countries. This dedicated geographical focus enables us to offer our reliable and highest-quality production assets to partners.
17.10.2024
CDMO medac group at CPHI in Milan
medac group, a reliable partner in contract development and manufacturing, is pleased to report a series of productive and insightful meetings with both current and potential business partners during this year’s CPHI Congress in Milan, held from 8–10 October 2024.
08.11.2024
Promising cooperation between medac and chiron for the development of organ-on chip technology
Testing new substances in animals is a regulatory cornerstone of drug development. At the same time, the development of animal free testing methods is progressing. In this context the pharmaceutical company medac and the start-up chiron biotechnology are working together on the further development and establishment of animal free testing methods for the pharmaceutical industry.